Assessment of Cetirizine, an Antihistamine, to Prevent Cutaneous Reactions to Nevirapine Therapy: Results of the Viramune‐Zyrtec Double‐Blind, Placebo‐Controlled Trial
Odile Launay(Délégation Paris 5), François‐André Allaert(McGill University), Olivier Lortholary(Hôpital Necker-Enfants Malades), B. Dupont(Délégation Paris 5), Renaud Urbinelli(Institution de Lavigny), Laurent Roudière(Hôpital Necker-Enfants Malades), Jean‐Marc Tréluyer(Hôpital Necker-Enfants Malades), Narjis Boukli(Boehringer Ingelheim (Egypt)), O. Patey(Centre Hospitalier Sud Francilien), Éric Caumes(Ollscoil na Gaillimhe – University of Galway), E. Rey(Hôpital Cochin), F. David(Institution de Lavigny), Françoise Clary(Assistance Publique – Hôpitaux de Paris), Christophe Piketty(Galderma (Switzerland)), A. Devidas(Centre Hospitalier Sud Francilien)
Cited by 23
Related Papers
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
|Clinical Infectious Diseases|2008|4.9k
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
|Science|2020|3.2k